Literature DB >> 1425721

Changes in the sensitivity of urinary pathogens to quinolones between 1987 and 1990 in France.

G Aubert, P P Levy, A Ros, R Meley, B Meley, A Bourge, G Dorche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1425721     DOI： 10.1007/bf01961870

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  Changes in the antibiotic sensitivities of urinary pathogens, 1971-1989.

Authors:  R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1990-12       Impact factor: 5.790

Review 2.  Norfloxacin: a new targeted fluoroquinolone antimicrobial agent.

Authors:  J S Wolfson; D C Hooper
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

3.  [Evolution from 1976 to 1986 of bacterial prevalence and sensitivity to urinary antibiotics of bacteria isolated from urine cultures at a city microbiology laboratory].

Authors:  J Chouteau
Journal:  Pathol Biol (Paris)       Date:  1988-05

4.  A critical evaluation of nalidixic acid in urinary-tract infections.

Authors:  A R Ronald; M Turck; R G Petersdorf
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

Review 5.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 6.  Bacterial resistance to fluoroquinolones.

Authors:  H C Neu
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

Review 7.  Use of quinolones in treatment of prostatitis and lower urinary tract infections.

Authors:  V T Andriole
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

8.  Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.

Authors:  M Kresken; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191
  8 in total
  4 in total

Review 1.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 2.  Risk factors for acquisition of multiply drug-resistant gram-negative bacteria.

Authors:  I M Gould
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

Review 3.  The epidemiology of bacterial resistance to quinolones.

Authors:  J F Acar; T F O'Brien; F W Goldstein; R N Jones
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 4.  Epidemiology of quinolone resistance: Europe and North and South America.

Authors:  F W Goldstein; J F Acar
Journal:  Drugs       Date:  1995       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.